After deliberating for only about three hours, a federal jury returned a verdict in favor of Merck in a lawsuit over the painkiller Vioxx, finding there was not enough evidence to link the drug to a Kentucky man's heart attack. Including Tuesday's verdict, the drugmaker so far has amassed a five-and-four record in state and federal courts in Vioxx-related cases. One expert who has tracked Vioxx litigation said he doesn't see Merck moving toward settling the many pending cases.
September 27, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
A federal jury ruled in favor of Merck & Co. Inc. on Tuesday in a lawsuit over the painkiller Vioxx, finding there was not enough evidence to link the drug to a Kentucky man’s heart attack.
The jury, made up of six women and two men, deliberated for only about three hours before reaching a verdict. The jurors left the courthouse without commenting on their decision.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
